Orgenesis Inc. Research and Development Expense of Revenue

Research and Development Expense of Revenue of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development Expense of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development Expense of Revenue for the quarter ending March 31, 2022 was 90.03% (a -41.18% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development Expense of Revenue increased by 0.23%
  • Annual Research and Development Expense of Revenue for 2021 was 100.75% (a -90.75% decrease from previous year)
  • Annual Research and Development Expense of Revenue for 2020 was 1089.69% (a 214.88% increase from previous year)
  • Annual Research and Development Expense of Revenue for 2019 was 346.06% (a 950.9% increase from previous year)
  • Twelve month Research and Development Expense of Revenue ending March 31, 2022 was 108.92% (a 8.11% increase compared to previous quarter)
  • Twelve month trailing Research and Development Expense of Revenue decreased by -62.31% year-over-year
Trailing Research and Development Expense of Revenue for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
108.92% 100.75% 233.72% 289.01%
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development Expense of Revenue of Orgenesis Inc.

Most recent Research and Development Expense of Revenueof ORGS including historical data for past 10 years.

Interactive Chart of Research and Development Expense of Revenue of Orgenesis Inc.

Orgenesis Inc. Research and Development Expense of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 90.03%
2021 153.05% 112.81% 89.82% 63.52% 100.75%
2020 2047.52% 393.23% 1406.86% 244.89% 1089.69%
2019 425.6% 59.9% 151.11% 1229.12% 346.06%
2018 58.0% 30.53% 19.76% 29.06% 32.93%
2017 19.52% 28.94% 40.01% 23.47%
2016 0.0% 41.91% 42.93% 0.0% 33.72%
2015 35.88%
2014 0.0%
2013 0.0%
2012 0.0%

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology